Stereotaxis, Inc. gears up for EHRA2026 with robotic EP technology preview

Stereotaxis, Inc. gears up for EHRA2026 with robotic EP technology preview
Stereotaxis, Inc. previews robotic EP

Stereotaxis, Inc. is preparing to attend the upcoming EHRA2026, inviting industry professionals to schedule meetings with its team. The company plans to present the latest advances in robotic electrophysiology (EP) at the event.

With less than one month remaining until EHRA2026, Stereotaxis, Inc. aims to engage with potential partners and medical experts to demonstrate its innovative solutions in the field. The event is expected to feature a range of cutting-edge technologies in cardiac care and robotic intervention.

Stereotaxis’s strategic focus at EHRA2026 builds on its ongoing commitment to advancing robotic platforms that shield both patients and clinicians from radiation exposure, as detailed in the company’s recent emphasis on how its RoboticEP platform addresses procedural safety concerns. The pursuit of industry engagement at the event further aligns with earlier initiatives encouraging direct experience of RoboticEP benefits through interactive demonstration, highlighting Stereotaxis’s continuous efforts to drive adoption of robotic innovation within cardiac care.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.